Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Covid 19 Infection, An Issue of Infectious Disease Clinics of North America
- 1st Edition, Volume 36-2 - June 2, 2022
- Editors: Rachel Bender Ignacio, Rajesh T. Gandhi
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 1 9 7 9 - 1
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 1 9 8 0 - 7
In this issue of Infectious Disease Clinics of North America, guest editors Drs. Rachel Bender Ignacio and Rajesh T. Gandhi bring their consi… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of Infectious Disease Clinics of North America, guest editors Drs. Rachel Bender Ignacio and Rajesh T. Gandhi bring their considerable expertise to the topic of COVID-19 Infection. The evolving virology, wide range of symptoms, long-term health issues, mortality rate, effect on hospitals, and high transmission rate have made COVID-19 one of the worst health crises in recent times. In this issue, top experts in the field address key issues such as diagnostic testing, COVID-19 in pediatrics, post-acute sequelae, infection control, and much more, aiming to arm clinicians with the information they need to combat this deadly infection.
-
Contains 15 relevant, practice-oriented topics including COVID-19 and global pandemic response, SARS CoV-2 transmission and prevention, COVID-19 Vaccines, COVID-19 treatment, equity and racial/ethnic disparities, and more.
-
Provides in-depth clinical reviews on COVID-19, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- Preface
- COVID-19 Pathogenesis and Clinical Manifestations
- Key points
- Introduction
- Pathogenesis
- Phases of infection
- Host immune responses
- Clinical Features
- COVID-19 in children
- Postacute sequelae of COVID-19
- Summary
- Clinics care points
- Disclosures
- SARS-CoV-2 Virology
- Key points
- Introduction
- Summary
- Clinics care points
- Funding sources
- Disclosure
- SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
- Key points
- Introduction
- Modes of transmission
- Determinants of infectiousness
- The period of infectiousness and serial interval
- Transmissibility and heterogeneity
- Transmission prevention with vaccination
- Transmission prevention
- Preliminary understanding of transmission dynamics of the omicron variant
- Summary
- Disclosure
- Awakening: The Unveiling of Historically Unaddressed Social Inequities During the COVID-19 Pandemic in the United States
- Key points
- Introduction
- Discussion
- Clinics care points
- Disclosure
- Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in Health Care Settings
- Key points
- Background
- Transmission of infectious agents
- Prevention of transmission in health care settings: implementation of the Hierarchy of Controls
- Elimination
- Substitution
- Engineering controls
- Personal protective equipment
- Evaluation and management of health care provider infections and exposures
- Transmission in health care settings and lessons learned
- Summary
- Clinics care points
- Laboratory Diagnosis for SARS-CoV-2 Infection
- Key points
- Introduction
- Summary
- Pharmacologic Treatment and Management of Coronavirus Disease 2019
- Key points
- Introduction
- Other clinical considerations when choosing coronavirus disease 2019 pharmacotherapies
- Management of ambulatory patients with mild or moderate coronavirus disease 2019 who are at risk for severe disease
- Neutralizing monoclonal antibody treatments
- Antiviral agents for ambulatory patients with mild or moderate coronavirus disease 2019
- Repurposed treatments
- What not to use in ambulatory patients with mild or moderate coronavirus disease 2019
- Pharmacologic treatment of patients hospitalized for mild or moderate coronavirus disease 2019
- Pharmacologic treatment of severe coronavirus disease 2019
- Pharmacologic treatment of patients with coronavirus disease 2019 needing noninvasive ventilation or high-flow oxygen
- Pharmacologic treatment of patients with coronavirus disease 2019 needing invasive mechanical ventilation or extracorporeal membrane oxygenation
- Summary
- Clinics care points
- Disclosure
- COVID-19 in the Critically Ill Patient
- Key points
- Introduction
- Epidemiology
- Pathogenesis and clinical features
- Diagnosis
- Treatment
- Clinics care points
- Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Key points
- Introduction
- Considered approach to the evaluation of patients with long coronavirus disease
- Prevention
- Discussion of next steps, challenges, and unanswered questions
- Summary
- Clinics care points
- COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
- Key points
- Human immunodeficiency virus
- COVID-19 in solid organ transplantion
- COVID-19 in hematopoietic stem cell transplant patients
- SARS-CoV-2 vaccination in hematopoietic cell transplant
- Quality of life during the pandemic
- COVID-19 in other immunocompromised populations
- Summary
- Clinics Care Points
- Disclosure
- COVID-19 and Pregnancy
- Key points
- Introduction
- Effects of SARS-CoV-2 infection during pregnancy
- Treatment of COVID-19 during pregnancy
- Effects of SARS-CoV-2 on pregnancy outcomes
- Intrauterine transmission of SARS-CoV-2
- SARS-CoV-2 vaccines and pregnancy
- Summary
- Clinics care points
- Disclosures
- Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children
- Key points
- Introduction
- Epidemiology
- Pediatric severe acute respiratory syndrome coronavirus 2 transmission
- Severe acute respiratory syndrome coronavirus 2 vaccinations in children
- Clinical course and manifestations of acute coronavirus disease 2019 in children
- Laboratory and imaging findings
- Clinical management considerations and coronavirus disease 2019 therapeutics
- Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- Post-acute sequelae of coronavirus disease 2019 in children
- Other health impacts on children during the coronavirus disease 2019 pandemic
- Summary
- Clinics care points
- COVID-19 Vaccines
- Key points
- Introduction
- Pfizer (BNT162b2)
- Janssen (Ad26.COV2.S)
- Vaccine safety gathered from postmarketing surveillance studies
- Key points [text box]
- Key points
- Key points
- Key points
- Postmarketing studies of real-world efficacy
- Need for additional doses beyond primary series (“booster doses”)
- Summary
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 36-2
- Published: June 2, 2022
- Imprint: Elsevier
- Hardback ISBN: 9780323919791
- eBook ISBN: 9780323919807
RB
Rachel Bender Ignacio
Affiliations and expertise
Assistant Professor, Allergy and Infectious Diseases, University of Washington, Medical Director, COVID-19 Clinical Research Clinic Associate, Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research CenterRG
Rajesh T. Gandhi
Affiliations and expertise
Associate Professor of Medicine, Harvard Medical School,Director of HIV Clinical Services and Education,Massachusetts General Hospital,